On the Fenton 2013 growth calculator page, the decision support was amended to include the 2014 AAP Policy Statement on RSV prophylaxis with palivizumab (reference link at the bottom of the page).

Because some units are continuing to use the 2009 guidelines, I have not removed the older policy recommendations (yet).